ConductScience.org, home

Paper18486992

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

Hansson O and 8 others. Neurobiol Aging, 2010. Cited by 238 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Papers, record 18486992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18486992

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
PubMed
Journal
Neurobiol Aging
PubMed
Year
2010
PubMed
Publication types
Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
238
iCite
Relative citation ratio, by iCite
6.9
iCite
Revised in PubMed
2022-04-09
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hansson OOskar
2Zetterberg HHenrik
3Vanmechelen EEugeen
4Vanderstichele HHugo
5Andreasson UUlf
6Londos EElisabet
7Wallin AAnders
8Minthon LLennart
9Blennow KKaj

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Amyloid beta-PeptidesMajor topic
Cognition DisordersMajor topic
Peptide FragmentsMajor topic
Aged
Aged, 80 and over
Biomarkers
Cohort Studies
Disease Progression
Eating
Female
Follow-Up Studies
Humans
Male
Middle Aged
Proportional Hazards Models
Risk Factors
Time Factors

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in18963255Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.https://conductscience.org/library/papers/18963255

Source PubMed

Download CSV of comments and corrections

Cited by136

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 238 citations.

PMIDTitleJournalYearIn PapersSource
42723835Expression differences and diagnostic efficacy of core plasma biomarkers in Alzheimer's disease, cerebral small vessel disease and healthy adults.Front Neurol2026https://conductscience.org/library/papers/42723835PubMed
42554173Plasma Concentrations of Amyloid-β Peptides, BACE-1, and Tau Proteins in Alzheimer's Disease.Turk J Pharm Sci2026https://conductscience.org/library/papers/42554173PubMed
41883006Generalizability of blood-based biomarkers of Alzheimer's disease and related dementias in a multicultural cohort of older adults: The effect of adjustment for kidney function.J Alzheimers Dis2026https://conductscience.org/library/papers/41883006PubMed
41756762The 2024 NIA-AA biological definition of Alzheimer's disease: linking biomarkers to clinical practice.Front Dement2026https://conductscience.org/library/papers/41756762PubMed
41683895Reduced Plasma Aβ Peptides but Stable NfL and GFAP in Major Depressive Disorder.Int J Mol Sci2026https://conductscience.org/library/papers/41683895PubMed
41252266Cross-sectional associations between lifecourse dementia risk factors, plasma neurodegenerative biomarkers, and cognition in older adults in India.J Alzheimers Dis2026https://conductscience.org/library/papers/41252266PubMed
41001466Cross-sectional associations between lifecourse dementia risk factors, plasma neurodegenerative biomarkers, and cognition in older adults in India.medRxiv2025https://conductscience.org/library/papers/41001466PubMed
40136456Older Amyloid Beta as a Candidate Blood Biomarker of Early Cognitive Decline in the Elderly-A Preliminary Study.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40136456PubMed
40091634Combination of Aβ40, Aβ42, and Tau Plasma Levels to Distinguish Amyloid-PET Positive Alzheimer Patients from Normal Controls.Exp Neurobiol2025https://conductscience.org/library/papers/40091634PubMed
40046335Plasma biomarkers for diagnosis and differentiation and their cognitive correlations in patients with Alzheimer's disease.Brain Commun2025https://conductscience.org/library/papers/40046335PubMed
40017276Association of Rapidly Elevated Plasma Tau Protein With Cognitive Decline in Patients With Amnestic Mild Cognitive Impairment and Alzheimer's Disease.Psychiatry Investig2025https://conductscience.org/library/papers/40017276PubMed
39881680MicroRNAs signatures as potential molecular markers in mild cognitive impairment: a meta-analysis.Front Aging Neurosci2024https://conductscience.org/library/papers/39881680PubMed
39474617Simple Plasma Test Based on a MoSe2 SERS Platform for the Specific Diagnosis of Alzheimer's Disease.Chem Biomed Imaging2023https://conductscience.org/library/papers/39474617PubMed
39309539Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives.Adv Funct Mater2023https://conductscience.org/library/papers/39309539PubMed
39185459Alzheimer's disease: a review on the current trends of the effective diagnosis and therapeutics.Front Aging Neurosci2024https://conductscience.org/library/papers/39185459PubMed
39125699Clinical Application of Blood Biomarkers in Neurodegenerative Diseases-Present and Future Perspectives.Int J Mol Sci2024https://conductscience.org/library/papers/39125699PubMed
39100640Advances in Blood Biomarkers for Alzheimer's Disease: Ultra-Sensitive Detection Technologies and Impact on Clinical Diagnosis.Degener Neurol Neuromuscul Dis2024https://conductscience.org/library/papers/39100640PubMed
39078432A mediation approach in resting-state connectivity between the medial prefrontal cortex and anterior cingulate in mild cognitive impairment.Aging Clin Exp Res2024https://conductscience.org/library/papers/39078432PubMed
37939982Menopausal vasomotor symptoms and plasma Alzheimer disease biomarkers.Am J Obstet Gynecol2024https://conductscience.org/library/papers/37939982PubMed
37762457Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers.Int J Mol Sci2023https://conductscience.org/library/papers/37762457PubMed

See all 136 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APP351PubTator's text mininghttps://conductscience.org/library/genes/351

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18486992

GET https://conductscience.org/api/papers/v1/18486992/cited_by?page=2